Summary of Changes
The T classification reflects the distinction between potentially resectable (T3) and locally advanced (T4) primary pancreatic tumors.
Stage grouping has been changed to allow Stage III to signify unresectable, locally advanced pancreatic cancer, while Stage IV is reserved for patients with metastatic disease.
Preview
Unable to display preview. Download preview PDF.
Bibliography
Albores-Saavedra J, Heffess C, Hruban RH, et al: Recommendations for the reporting of pancreatic specimens containing malignant tumors. Am J Clin Pathol 111:304–307, 1999
Association of Directors of Anatomic and Surgical Pathology: Recommendations for the reporting of pancreatic specimens containing malignant tumors. Hum Pathol 29:893–895, 1998
Birkmeyer JD, Finlayson SR, Tosteson AN, et al: Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy. Surgery 125:250–256, 1999
Birkmeyer JD, Warshaw AL, Finlayson SR, et al: Relationship between hospital volume and late survival after pancreaticoduodenectomy. Surgery 126:178–183, 1999
Bold RJ, Charnsangavej C, Geary KR, et al: Major vascular resection as part of pancreaticoduodenectomy for cancer: radiologic, intraoperative, and pathologic analysis. J Gastrointest Surg 3:233–243, 1999
Compton CC, Henson DE: Protocol for the examination of specimens removed from patients with carcinoma of the exocrine pancreas: a basis for checklists. Arch Pathol Lab Med 121:1129–1136, 1997
Conlon KC, Klimstra DS, Brennan MF: Long-term survival after curative resection for pancreatic ductal adenocarcinoma: clinicopathologic analysis of 5-year survivors. Ann Surg 223:273–279, 1996
Cubilla AL, Fitzgerald PJ: Tumors of the exocrine pancreas. In Atlas of tumor pathology, 2nd series, facicle 19, Washington DC: Armed Forces Institute of Pathology, 1984
Cubilla AL, Fortner J, Fitzgerald PJ. Lymph node involvement in carcinoma of the head of the pancreas area. Cancer 41:880–887, 1978
Evans DB, Abbruzzese JL, Willett CG. Cancer of the pancreas. In DeVita VT, Hellman S, Rosenberg SA (Eds): Cancer, prin- | ciples and practice of oncology, 6th ed. Philadelphia: J.B. Lippincott, 2002
Evans DB, Lee JE, Pisters PWT: Pancreaticoduodenectomy (Whipple operation) and total pancreatectomy for cancer. In Nyhus LM, Baker RJ, Fischer JF (Eds.): Mastery of surgery, 3rd ed. Boston: Little, Brown, 1233–1249, 1997
Fuhrman GM, Charnsangavej C, Abbruzzese JL, et al: Thin-section contrast-enhanced computed tomography accurately predicts resectability of malignant pancreatic neoplasms. Am J Surg 167:104–111, 1994
Geer RJ, Brennan MF: Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165:68–72, 1993
Gold EB, Goldin SB: Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin N Am 7:67–91, 1998
Greenlee RT, Murray T, Bolden S, et al: Cancer statistics, 2000. CA Cancer J Clin 50:7–13, 2000
Griffin JF, Smalley SR, Jewell W: Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66:56–61, 1990
Kloppel G, Hruban RH, Longnecker DS, Adler G, Kern SE, Partanen TJ. Ductal adenocarcinoma of the pancreas. In Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumors: Pathology and Genetics, Tumors of the Digestive System. Lyon, IARC Press, 2000, pp 221–230.
Leach SD, Lee JE, Charnsangavej C, et al: Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 85:611–617, 1998
Millikan KW, Deziel DJ, Silverstein JC, et al: Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 65:618–624, 1999
Nitecki SS, Sarr MG, Colby TV, et al: Long-term survival after resection for ductal adenocarcinoma of the pancreas: is it really improving? Ann Surg 221:59–66, 1995
Pedrazzoli S, Bger HG, Obertop H, et al: A surgical and pathological based classification of resective treatment of pancreatic cancer. Dig Surg 16:337–345, 1999
Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg. 4:567–579, 2000.
Staley C, Geary K, Abbruzzese J, et al: Need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 12:373–380, 1996
Suits J, Frazee R, Erickson RA: Endoscopic ultrasound and fine-needle aspiration for the valuation of pancreatic masses. Arch Surg 134:639–643, 1999
Traverso LW, Longmire WP Jr: Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 146:959–962, 1978
Tyler DS, Evans DB: Reoperative pancreaticoduodenectomy. Ann Surg 219:211–221, 1994
Westerdahl J, Andren-Sandeberg A, Ihse I: Recurrence of exocrine pancreatic cancer—local or hepatic? Hepatogastroen-terology 40:384–387, 1993
Whipple AO, Parsons WW, Mullin CR: Treatment of carcinoma of the ampulla of Vater. Ann Surg 102:763–269, 1935
Willett CG, Lewandrowski K, Warshaw AL, et al: Resection margins in carcinoma of the head of the pancreas: implications for radiation therapy. Ann Surg 217:144–148, 1993
Yeo CJ, Cameron JL, Sohn TA, et al: Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226:248–257, 1997
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
American Joint Committee on Cancer. (2002). Exocrine Pancreas. In: Greene, F.L., et al. AJCC Cancer Staging Manual. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-3656-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3656-4_18
Publisher Name: Springer, New York, NY
Print ISBN: 978-3-540-00595-7
Online ISBN: 978-1-4757-3656-4
eBook Packages: Springer Book Archive